Cátedra de Riesgo Cardiovascular, Universidad de Salamanca, Spain.
Eur J Intern Med. 2010 Apr;21(2):118-22. doi: 10.1016/j.ejim.2009.12.013. Epub 2010 Feb 1.
The aim of this study was to investigate the arterial stiffness parameters derived from the proposed linear relationship between SBP and DBP obtained by ABPM, regarding its relationships with two markers of renal disease, microalbuminuria and renal function.
One hundred and sixty six patients were studied: 73 males and 93 females mean age 55.2+/-15.5 years. 36.2% were receiving antihypertensive drug treatment. Microalbuminuria was measured in 24-h urine collection as well as albumin to creatinine ratio (ACR) in first morning urine. The ambulatory BP was measured non-invasively for 24 h by the Spacelab devices.
Correlation test showed a significant relationship of Sym-AASI with age (p<0.001), serum creatinine (p=0.038), creatinine clearance (-0.423, p<0.001) and GFR (-0.263, p<0.001). On the other hand AASI was also correlated with age (p<0.001) and creatinine clearance (p=0.012), but not with the other parameters studied. 24-h albumin excretion rate was not correlated with Sym-AASI or AASI. Contrariwise, the albumin to creatinine ratio was correlated with Sym-AASI (p=0.013). As expected, AASI and Sym-AASI increase as severity of renal diseases grows. The patients in the highest quartile of Sym-AASI distribution showed an older age (p<0.001) and worse parameters of renal function (GFR, p<0.001; and creatinine clearance, p<0.008).
Sym-AASI, an improved method for detecting arterial stiffness, seems to get an independent relationship with these parameters of renal disease which could not be detected with AASI.
本研究旨在探讨通过 ABPM 获得的 SBP 和 DBP 之间提出的线性关系得出的动脉僵硬度参数与两种肾脏疾病标志物(微量白蛋白尿和肾功能)之间的关系。
共研究了 166 例患者:73 名男性和 93 名女性,平均年龄 55.2±15.5 岁。36.2%正在接受降压药物治疗。通过 24 小时尿液收集测量微量白蛋白尿,并在第一次晨尿中测量白蛋白与肌酐比值(ACR)。使用 Spacelab 设备无创地测量 24 小时动态血压。
相关检验显示,Sym-AASI 与年龄(p<0.001)、血清肌酐(p=0.038)、肌酐清除率(-0.423,p<0.001)和肾小球滤过率(-0.263,p<0.001)显著相关。另一方面,AASI 也与年龄(p<0.001)和肌酐清除率(p=0.012)相关,但与其他研究参数无关。24 小时白蛋白排泄率与 Sym-AASI 或 AASI 均不相关。相反,白蛋白与肌酐比值与 Sym-AASI 相关(p=0.013)。正如预期的那样,随着肾脏疾病严重程度的增加,AASI 和 Sym-AASI 增加。Sym-AASI 分布的最高四分位数患者年龄较大(p<0.001),肾功能参数较差(GFR,p<0.001;和肌酐清除率,p<0.008)。
Sym-AASI 是一种检测动脉僵硬度的改良方法,似乎与这些无法用 AASI 检测到的肾脏疾病参数有独立关系。